The concept of clinically meaningful difference in health-related quality-of-life research - How meaningful is it?

被引:392
作者
Hays, RD
Woolley, JM
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA
[2] RAND, Santa Monica, CA USA
[3] Amgen Inc, Thousand Oaks, CA 91320 USA
关键词
Meaningful Difference; Physical Component Summary; Minimal Clinically Important Difference; Mental Health Component Summary; Mental Health Component Summary Score;
D O I
10.2165/00019053-200018050-00001
中图分类号
F [经济];
学科分类号
02 ;
摘要
It is generally believed that small differences in health-related quality of life (HR-QOL) may be statistically significant yet clinically unimportant. The concept of the minimal clinically meaningful difference (MCID) has been proposed to refer to the smallest difference in a HR-QOL score that is considered to be worthwhile or clinically important. However, there is danger in oversimplification in asking the question: what is the MCID on this HR-QOL instrument? We argue that the attempt to define a single MCID is problematic for a number of reasons and recommend caution in the search for the MCID holy grail. Specifically, absolute thresholds are suspect because they ignore the cost or resources required to produce a change in HR-QOL. In addition, there are several practical problems in estimating the MCID, including: (i) the estimated magnitude varies depending on the distributional index and the external standard or anchor; (ii) the amount of change might depend on the direction of change; and (iii) the meaning of change depends on where you start (baseline value).
引用
收藏
页码:419 / 423
页数:5
相关论文
共 15 条
  • [1] Understanding changes in health status - Is the floor phenomenon merely the last step of the staircase?
    Baker, DW
    Hays, RD
    Brook, RH
    [J]. MEDICAL CARE, 1997, 35 (01) : 1 - 15
  • [2] Impact of the global on patient perceivable change in an asthma specific QOL questionnaire
    Barber, BL
    Santanello, NC
    Epstein, RS
    [J]. QUALITY OF LIFE RESEARCH, 1996, 5 (01) : 117 - 122
  • [3] SIMILARITY EQUIVALENCE TRIALS FOR COMBINATION VACCINES
    BLACKWELDER, WC
    [J]. COMBINED VACCINES AND SIMULTANEOUS ADMINISTRATION: CURRENT ISSUES AND PERSPECTIVES, 1995, 754 : 321 - 328
  • [4] A POWER PRIMER
    COHEN, J
    [J]. PSYCHOLOGICAL BULLETIN, 1992, 112 (01) : 155 - 159
  • [5] Cohen J., 1998, Statistical Power Analysis for the Behavioral Sciences, V2nd
  • [6] Hays R D, 1992, Qual Life Res, V1, P73, DOI 10.1007/BF00435438
  • [7] MEASUREMENT OF HEALTH-STATUS - ASCERTAINING THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE
    JAESCHKE, R
    SINGER, J
    GUYATT, GH
    [J]. CONTROLLED CLINICAL TRIALS, 1989, 10 (04): : 407 - 415
  • [8] USING HEALTH-STATUS MEASURES IN THE HOSPITAL SETTING - FROM ACUTE CARE TO OUTCOMES MANAGEMENT
    LANSKY, D
    BUTLER, JBV
    WALLER, FT
    [J]. MEDICAL CARE, 1992, 30 (05) : MS57 - MS73
  • [9] A QUALITY-OF-LIFE STUDY IN 581 DUODENAL-ULCER PATIENTS - MAINTENANCE VERSUS INTERMITTENT TREATMENT WITH NIZATIDINE
    RAMPAL, P
    MARTIN, C
    MARQUIS, P
    WARE, JE
    BONFILS, S
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 : 44 - 51
  • [10] Determining clinically important differences in health status measures - A general approach with illustration to the Health Utilities Index Mark II
    Samsa, G
    Edelman, D
    Rothman, ML
    Williams, GR
    Lipscomb, J
    Matchar, D
    [J]. PHARMACOECONOMICS, 1999, 15 (02) : 141 - 155